Abbott Laboratories and Myriad Genetics have extended a research partnership focusing on how an individual's genetic makeup affects their response to medicine. The deal calls for Abbott to fund the research and for Salt Lake City-based Myriad to use its technology and mutation screening software to analyze samples from different populations.
Biotech associations in Sweden, France, Finland, Norway and Estonia are backing a project designed to encourage development of globally competitive R&D companies. The sponsors see the initiative as a way to encourage further biotechnology development and help overcome public resistance to biotech crops in Europe.
A senior scientist at the International Rice Research Institute predicts Asian countries will overcome concerns about biotech crops and regulatory impediments to approval in the next five to seven years as population pressure increases.
New York Gov. George Pataki has mandated that at least 5% of the fuel used to heat state buildings must be biodiesel by 2012 in order to decrease the state's dependence on foreign oil. He also said companies willing to create bio-refineries in New York will receive incentives.
San Diego's Protein Polymer Technologies announced a merger with the Irvine-based Thuris, a privately held biopharmaceutical firm. Thuris works on medical devices that aid in drug development and diagnosis of central nervous system disorders and also is developing pharmaceuticals for some CNS orphan and niche indications.